Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-8020
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments ; volume:6 ; number:1 ; day:13 ; month:7 ; year:2022 ; pages:1-11 ; date:12.2022
Journal of patient-reported outcomes ; 6, Heft 1 (13.7.2022), 1-11, 12.2022
- Urheber
-
Raymond, Kimberly
Vallow, Susan
Saucier, Cory
Jackson, Kristi
White, Michelle K.
Lovley, Andrew
D’Alessio, Denise
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41687-022-00481-8
- URN
-
urn:nbn:de:101:1-2022091810474460395156
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raymond, Kimberly
- Vallow, Susan
- Saucier, Cory
- Jackson, Kristi
- White, Michelle K.
- Lovley, Andrew
- D’Alessio, Denise
- SpringerLink (Online service)
Ähnliche Objekte (12)
PIK3CA-related overgrowth with an uncommon phenotype: case report
Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Clinical and genetic analyses of patients with lateralized overgrowth
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene
Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth
Communication with cancer patients: the perspective of caregivers versus non-caregivers in Iran
Antimicrobial treatment improves tryptophan metabolism and mood of patients with small intestinal bacterial overgrowth
PIK3CA-related overgrowth with an uncommon phenotype: case report
Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Clinical and genetic analyses of patients with lateralized overgrowth
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene
Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth
Communication with cancer patients: the perspective of caregivers versus non-caregivers in Iran
Antimicrobial treatment improves tryptophan metabolism and mood of patients with small intestinal bacterial overgrowth
PIK3CA-related overgrowth with an uncommon phenotype: case report
Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Clinical and genetic analyses of patients with lateralized overgrowth
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene
Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth
Communication with cancer patients: the perspective of caregivers versus non-caregivers in Iran